Individualised controlled ovarian stimulation (iCOS): maximising success rates for assisted reproductive technology patients

por Bosch, Ernesto, Ezcurra, Diego
Publicado 2011

Predicting and preventing ovarian hyperstimulation syndrome (OHSS): the need for individualized not standardized treatment

por Fiedler, Klaus, Ezcurra, Diego
Publicado 2012

A review of luteinising hormone and human chorionic gonadotropin when used in assisted reproductive technology

por Ezcurra, Diego, Humaidan, Peter
Publicado 2014

Human steroidogenesis: implications for controlled ovarian stimulation with exogenous gonadotropins

por Andersen, Claus Y, Ezcurra, Diego
Publicado 2014

Hormonal, functional and genetic biomarkers in controlled ovarian stimulation: tools for matching patients and protocols

por Alviggi, Carlo, Humaidan, Peter, Ezcurra, Diego
Publicado 2012

Recombinant human follicle-stimulating hormone produces more oocytes with a lower total dose per cycle in assisted reproductive technologies compared with highly purified human men...

por Lehert, Philippe, Schertz, Joan C, Ezcurra, Diego
Publicado 2010

The Human Oocyte Preservation Experience (HOPE) a phase IV, prospective, multicenter, observational oocyte cryopreservation registry

por Ezcurra, Diego, Rangnow, Jennifer, Craig, Maryellen, Schertz, Joan
Publicado 2009

A questionnaire-based survey to assess patient satisfaction, ease-of-learning, ease-of-use, injection site pain and overall patient satisfaction of the follitropin-alpha (Gonal-f)...

por Utsunomiya, Takafumi, Tanaka, Atsushi, Tatsumi, Kenichi, Ezcurra, Diego
Publicado 2012

Assessment of the biopotency of follitropin alfa and lutropin alfa combined in one injection: a comparative trial in Sprague-Dawley rats

por Alper, Michael, Meyer, Randal, Dekkers, Chris, Ezcurra, Diego, Schertz, Joan, Kelly, Eduardo
Publicado 2008